üma Laboratories
Laboratoires üma develops products targeting the physiological changes associated with perimenopause, menopause, and post-menopause.
$2M Seed ·
Source: frenchweb.fr
Funding history ↓Signals
Website registeredSep 20, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $2M | — | frenchweb.fr |
Timeline
- Website created
Founders and team
PT
Priscaël T. Founder
Investors
Similar Health and bio companies
CCAD TherapeuticsSeries A · Oct 2026
SSeawolf Therapeutics$100M Seed · Nov 2026
TTestDynamics$9M Series A · Nov 2026
IINFevo$15M Seed · Nov 2026
KKnit Health$35M Seed · Nov 2026
RRemedy Robotics$62M Series A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/uma-laboratories (get a free API key).